Monthly Archives: August 2016

D., for his review and comments on the manuscript. The authors also thank Vikhyat Bebarta, M.D., for his insight into the issue of the quality of published case reports. Dr. Heard was supported by DA020573 from the National Institute on … Continue reading →

Brock. These fetal interventions may have improved survival by improving pulmonary development, but there remains significant high risk for longterm renal morbidity. The ideal fetus for intervention with lower urinary tract obstruction remains unknown at this time. The third condition … Continue reading →

The problem arises from the difficulties in performing a standard neuropsychological battery, which is generally made by tests and self-reports. Clinical evidence shows that it is sometimes almost impossible to perform a correct patients’ evaluation with such instruments. In our … Continue reading →

Information was available on 38,762 patients for inclusion. Four-level triage scale (P1 to P4) is used in the AKUH ED and was used for the purpose of this study. Patients with life threatening conditions are labeled P1, those in a … Continue reading →

144 One recent study reported an increased expression of dopamine D3 receptors in the nucleus accumbens.145 In addition to studies of dopamine receptors, there have been recent studies of dopamine release and intrasynaptic dopamine content in the striatum. Two groups … Continue reading →

Initial results have suggested an advantage for cognitive impairment29,102-105 and for negative symptoms,95,106-110 but these advantages have not been consistent across trials.19,42,86,111-114 Combined antipsychotic drugs The assumption that broader or higher level of receptor binding could lead to improved efficacy … Continue reading →

Treatment of psychiatric illnesses, such as depression and schizophrenia, with tACS has not yet been evaluated. However, preliminary success with tDCS further supports the pursuit of noninvasive, therapeutic brain stimulation for depression70-72 and other psychiatric illnesses.73 In contrast to today’s … Continue reading →

41-45 In some, but not all,46 experimental paradigms, estradiol has been observed to inhibit serotonin reuptake transporter (SERT) mRNA47 and decrease activity at serotonin (5-hydroxytryptaminc) 5-HT1A receptors,48,49 consistent with some reported actions of antidepressants on serotonergic system function. Moreover, in … Continue reading →

33,34 A recent selleck kinase inhibitor meta-analysis of studies on prevention of PPD did not find clear evidence that preventive interventions during pregnancy may reduce the incidence of postpartum depression.27 This meta-analysis did not, however, focus on studies in which … Continue reading →

, with no cardiac event reported [70]. Different schedules and doses have been investigated in an effort to improve tolerability while maintaining antitumor efficacy [28, 35, 36, 71]. Several studies have shown that a more acceptable toxicity profile, in terms … Continue reading →